GLP-1 Clinical & Lifestyle Support
Maximize GLP-1 outcomes with virtual integrated care and medication management
Platform · Cloud SaaSCompany source
Company profile
About Cecelia Health
Cecelia Health operates as a virtual specialty medical practice delivering integrated cardiometabolic care that treats the whole patient rather than isolated conditions. The company provides comprehensive clinical support for individuals managing multiple chronic conditions including obesity, diabetes, hypertension, chronic kidney disease, respiratory conditions, and cardiovascular disease. Their care model combines virtual clinical support, comorbid medication management, remote monitoring, medical nutrition therapy, clinical-grade lifestyle interventions, and culturally-relevant care delivered by a national network of licensed clinicians including registered dietitians, certified diabetes care and education specialists (CDCES), registered nurses, and physician specialists. Cecelia Health specializes in GLP-1 medication management with clinical and lifestyle support, helping organizations optimize medication use while achieving sustainable weight loss and health outcomes. The company serves health systems, payers, employers, and pharmaceutical companies, delivering measurable clinical and financial results including up to 18% average weight loss, 1.5-point A1C reduction, 16% medical cost savings, and up to 40% lower GLP-1 spend. With over 15 years of experience in chronic care delivery, Cecelia Health maintains a 90% engagement rate and 93% member satisfaction while providing coordinated care that integrates with members' existing healthcare providers.
Company description Cecelia Health official website
Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Work at Cecelia Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cardiovascular disease
- chronic kidney disease
- diabetes
- hypertension
- obesity
- respiratory conditions
- sleep apnea
Who it serves
- Employers
- Health Systems
- Payers
- Pharma
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Expanded GLP-1 clinical and lifestyle support programs, demonstrated up to 40% reduction in GLP-1 medication spend for employers, achieved 18% average weight loss outcomes
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Integrated Cardiometabolic Care
Virtual specialty medical practice for coordinated chronic condition management
Platform · Cloud SaaSCompany source
Lifestyle-Driven Weight Management for Employers
Clinician-led weight management program for employers to optimize GLP-1 use and reduce costs
Platform · Cloud SaaSCompany source
Patient Support for Pharma
Patient support solutions for pharmaceutical companies
Service · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Older Adults Benefit From Virtual Support for Continuous Glucose Monitor Use But Require Longer Visits.Journal of diabetes science and technology · May 1, 2026
Assessing the Financial Sustainability of a Virtual Clinic Providing Comprehensive Diabetes Care.Journal of diabetes science and technology · May 13, 2025
Patient-Reported Outcomes Improve with a Virtual Diabetes Care Model that Includes Continuous Glucose Monitoring.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · Jan 1, 2025
Comprehensive Telehealth Model to Support Diabetes Self-Management.JAMA network open · Oct 2, 2023
2022 National Standards for Diabetes Self-Management Education and Support.The science of diabetes self-management and care · Feb 1, 2022
Diabetes Education and Support Tele-Visit Needs Differ in Duration, Content, and Satisfaction in Older Versus Younger Adults.Telemedicine reports · Jan 1, 2022
Clinical validation
Clinical-trial records
Evidence for Health Improvement in People With Diabetes Using One Touch & Partner SolutionsNCT05354297 · Mentioned · UNKNOWN
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
18% average weight loss
Members in weight management program
1.5pt average A1c reduction
Diabetes management
60% reach hypertension control within 5 months
Hypertension management
16% medical cost savings
Overall program impact
Up to 40% lower GLP-1 spend
Optimized GLP-1 prescribing and waste reduction
90% engagement rate
Member participation sustained over time
93% member satisfaction
Overall program satisfaction
4.0x ROI
Return on investment
37-point improvement in medication adherence
Medication management
38% reduction in claims costs
Integrated comorbidity management
94% weight loss maintenance after 6 months
Members who discontinue GLP-1s but remain in lifestyle program
Employer Population (GLP-1 Weight Management)
Managing GLP-1 costs and improving weight loss outcomes for employee population
Up to 40% lower GLP-1 spend, 18% average weight loss, 38% reduction in claims costs, 94% weight loss maintenance after GLP-1 discontinuation
General Population Outcomes
Delivering integrated cardiometabolic care across multiple chronic conditions with virtual specialty medical practice
16% medical cost savings, 90% engagement rate, 93% member satisfaction, 4.0x ROI
Integrated Cardiometabolic Care Population
Improving cardiometabolic health outcomes across multiple chronic conditions including diabetes, obesity, hypertension, and chronic kidney disease
Up to 18% average weight loss, 1.5pt average A1c reduction, 60% of patients reach hypertension control within 5 months, 37-point improvement in medication adherence
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Cecelia Health
Recent articles published on Cecelia Health's official website.
The Impact of Potassium on CKD: What You Need to Know
Read on Cecelia HealthTips for getting enough protein on a vegetarian diet
Read on Cecelia HealthHow Sleep Apnea Affects Your Heart, Brain, and Energy Levels
Read on Cecelia HealthCan Weight Loss Medications Help with Sleep Apnea?
Read on Cecelia HealthWhy is Asthma Worse in the Early Morning
Read on Cecelia Health07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.